Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009

Pain Research and Management

Volumn 18, Issue 2, 2013, Pages 69-74

  Shield, KevinD ^a,b   Jones, Wayne ^c   Rehm, Jürgen ^a,b,d,e   Fischer, Benedikt ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Canada; General population surveys; Pain care; Prescription opioids; Substance abuse

Indexed keywords

OPIATE; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHRONIC PAIN; DRUG MISUSE; DRUG USE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONMEDICAL PRESCRIPTION OPIOID ANALGESIC USE; PAIN; SEX DIFFERENCE;

EID: 84878327704     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/651649     Document Type: Article

References (46)

1. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain 2008;24:469-78.
2. Gardner-Nix J. Principles of opioid use in chronic noncancer pain. CMAJ 2003;169:38-43. (Pubitemid 36898076)
3. Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A; National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 1: General population. Can Fam Physician 2011;57:1257-66.
4. Manchikanti L, Abdi S, Atluri S, et al American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I - evidence assessment. Pain Physician 2012;15:S1-S65.
5. Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15:ES67-ES92.
6. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011;305:346-7.
7. Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician 2012;15:ES191-ES203.
8. Substance Abuse Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, Maryland: Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2010.
9. Centers for Disease Control Prevention. Vital Signs: Overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011;60:1487-92.
10. Hansen RN, Oster G, Edelsberg J, Woody GE, Sullivan SD. Economic costs of nonmedical use of prescription opioids. Clin J Pain 2011;27:194-202.
11. National Survey on Drug Use and Health. Trends in Non-medical use of Prescription Pain Relievers: 2002 to 2007. Canberra, Australia: The Australian Institute of Health and Welfare, 2008.
12. United Nations Office on Drugs and Crime. World Drug Report. Vienna, Austria: United Nations Office on Drugs and Crime, 2011.
13. Fischer B, Nakamura N, Ialomiteanu A, Boak A, Rehm J. Assessing the prevalence of non-medical prescription opioid use in the general Canadian population: Methodological issues and questions. Can J Psychiatry 2010;55:606-9.
14. Dhalla IA, Mamdani MM, Sivilotte ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181:891-6.
15. Shield KD, Ialomiteanu A, Fischer B, Mann RE, Rehm J. Non-medical use of prescription opioids among Ontario adults: Data from the 2008/2009 CAMH Monitor. Can J Public Health 2011;102:330-5.
16. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey 2009: Microdata user guide. Ottawa, Canada: Health Canada, 2010.
17. Fischer B, Nakamura N, Urbanoski K, Rush B, Rehm J. Correlations between population levels of prescription opioid use and PULSUS GROUP prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health 2012;126:749-51.
18. Wisniewski AM, Purdy CH, Bondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 2008;27:1-11.
19. Dasgupta N, Kramer ED, Zalman MA, et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006;82:135-42.
20. Morgan SG, Raymond C, Mooney D, et al. The Canadian Rx Atlas, 2nd Edition. UBC Centre for Health Services and Policy Research. Vancouver, British Columbia, 2008.
21. Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels and trends of prescription opioid analgesic (POA) use dispensed from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 2011;20:1269-77.
22. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey 2008: Microdata User Guide. Health Canada. 〈http://prod.library.utoronto.ca/ datalib/codebooks/cstdli/cadums/2008/cadums-technical-guide-2008-final-eng. pdf〉 (Accessed 2009).
23. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey 2010: Microdata user guide. Ottawa, Canada: Health Canada, 2011.
24. AIMS. L'Association de l'Industrie de la Recherche Marketing et Sociale. Quantitative Norms, 2010.
25. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2010. Norwegian Institute of Public Health. 〈www.whocc.no/atc-ddd-index/〉 (Accessed 2009).
26. Lumley T. Analysis of complex survey samples. J Stat Softw 2004;9:1-19. (Pubitemid 39217809)
27. R Development Core Team. R: A Language and Environment for Statistical Computing (version 2.13.0). Vienna, Austria: R Foundation for Statistical Computing, 2011.
28. International Narcotics Control Board. Narcotic drugs: Estimated world requirements for 2012, statistics for 2010. Vienna, Austria: International Narcotics Control Board, 2011.
29. Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. J Substance Abuse 1998;10:163-73.
30. DeWit DJ, Adlaf EM, Offord DR, Ogborne AC. Age at first alcohol use: A risk factor for the development of alcohol disorders. Am J Psychiatry 2000;157:745-50. (Pubitemid 30249653)
31. Kessler RC, Chiu WT, Demier O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27. (Pubitemid 40973437)
32. Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 2008;103:258-68.
33. Reitsma ML, Tranmer JE, Buchanan DM, Vandenkerkhof EG. The prevalence of chronic pain and pain-related interference in the Canadian population from 1994-2008. Chronic Dis Can 2011;31:157-64.
34. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GL. Chronic pain in Canada: Have we improved our management of chronic noncancer pain? Pain Res Manag 2007;12:39-47. (Pubitemid 46744776)
35. Lynch ME, Fischer B. Prescription opioid abuse: What is the real problem and how do we fix it? Can Fam Physician 2011;57:1241-2, e1403-5.
36. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
37. Smith HS. Conventional practice for medical conditions for chronic opioid therapy. Pain Physician 2012;15:ES1-ES7.
38. Manchikanti L, Abdi S, Atluri S, et al American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2 - guidance. Pain Physician 2012;15:S67-S116.
39. McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007;32:562-75. (Pubitemid 46038570)
40. Fischer B, Rehm J. Nonmedical use of prescription opioids: Furthering a meaningful research agenda. J Pain 2008;9:490-3. (Pubitemid 351726521)
41. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Safety 2008;17:997-1005.
42. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010;18:21.
43. Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009 Pharmacoepidemiol Drug Safety. In Press.
44. Shield K, Rehm J. Difficulties with telephone-based surveys on alcohol in high-income countries: The Canadian example. Int J Method Psych 2012;21:17-28.
45. Zhao J, Stockwell T, Macdonald S. Non-response bias in alcohol and drug population surveys. Drug Alcohol Rev 2009;28:648-57.
46. Sudman S, Bradburn N, Schwarz N. Thinking About Answers: The Application Of Cognitive Processes To Survey Methodology. San Francisco: Jossey-Bass, 1996.